Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei
Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei
Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei
Submitted by
admin
on March 13, 2018 - 10:13am
Source:
Endpoints
News Tags:
Teva Pharmaceutical
CGRP blockers
R&D
drug development
Heptares Therapeutics
Headline:
Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei
Do Not Allow Advertisers to Use My Personal information
